- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Leerink Partners raises Penumbra stock price target on MMA embolization potential | ||
| Fr | Constellation Brands stock price target raised to $197 by Bernstein | ||
| Fr | FTAI Aviation stock price target raised to $327 from $240 at Compass Point | ||
| Fr | Benchmark reiterates Buy rating on Penske Automotive stock, maintains $190 target | ||
| Fr | Cantor Fitzgerald reiterates Overweight rating on Supernus Pharmaceuticals stock | ||
| Fr | Krystal Biotech stock maintains Overweight rating at Cantor Fitzgerald | ||
| Fr | Needham reiterates Buy rating on Credo Technology stock, adds to Conviction List | ||
| Fr | Fermi stock rating reiterated at Overweight by Cantor Fitzgerald | ||
| Fr | Legal & General UCITS ETF announces dividend payments for 11 funds | ||
| Fr | Wellington Management discloses 7.47% stake in Permanent TSB | ||
| Fr | Guggenheim raises Neogen stock price target to $12 on strong Food Safety results | ||
| Fr | Helen of Troy stock price target lowered to $22 at Canaccord on tariff pressures | ||
| Fr | Globus Medical stock price target raised to $112 by Canaccord on strong results | ||
| Fr | Ping An Biomedical secures investment from three notable investors | ||
| Fr | uniQure schedules FDA meeting to discuss accelerated approval for HD therapy | ||
| Fr | Amarin highlights VASCEPA's role amid new triglyceride therapies | ||
| Fr | Schrödinger partners with Lilly TuneLab to enhance drug discovery | ||
| Fr | Immunocore outlines 2026 strategy at J.P. Morgan conference | ||
| Fr | Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy | ||
| Fr | iBio secures $26 million in private placement financing | ||
| Fr | FDA identifies deficiencies in Aquestive's Anaphylm application | ||
| Fr | MapLight Therapeutics accelerates timeline for Phase 2 trial results | ||
| Fr | Polestar reports 34% growth in 2025 retail sales to 60,119 cars | ||
| Fr | BofA Securities raises Gilead Sciences stock price target to $154 on HIV franchise strength | ||
| Fr | Southwest stock rating upgraded by JPMorgan on strong EPS outlook |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .